Intranasally administered immunoglobulin for the prevention of rhinitis in children

Pediatric Infectious Disease Journal

Volumn 17, Issue 5, 1998, Pages 367-372

  Heikkinen, Terho ^a,d   Ruohola, Aino ^a   Ruuskanen, Olli ^a   Waris, Matti ^a   Uhari, Matti ^b   Hammarström, Lennart ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Child; Immunoglobulin A; Immunoglobulin G; Nasal mucosa; Passive immunization; Prevention and control; Respiratory tract infections

Indexed keywords

IGABULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE COURSE; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FEVER; FINLAND; HUMAN; INTRANASAL DRUG ADMINISTRATION; MALE; MUCOSAL IMMUNITY; OTITIS MEDIA; PASSIVE IMMUNIZATION; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS;

EID: 0031750362     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199805000-00004     Document Type: Article

References (30)

1. Garibaldi RA. Epidemiology of community-acquired respiratory tract infections in adults: incidence, etiology, and impact. Am J Med 1985;78(Suppl 6B):32-7.
2. Dixon RE. Economic costs of respiratory tract infections in the United States. Am J Med 1985;78(Suppl 6B):45-51.
3. Monto AS, Ullman BM. Acute respiratory illness in an American community: the Tecumseh study. JAMA 1974;227: 164-9.
4. Ruuskanen O, Arola M, Putto-Laurila A, et al. Acute otitis media and respiratory virus infections. Pediatr Infect Dis J 1989;8:94-9.
5. McNabb PC, Tomasi TB. Host defense mechanisms at mucosal surfaces. Annu Rev Microbiol 1981;35:477-96.
6. Murphy BR. Mucosal immunity to viruses. In: Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J, eds. Handbook of mucosal immunology. San Diego: Academic, 1994:333-43.
7. Stenfors LE, Räisänen S. Secretory IgA-and IgG-coated bacteria in the nasopharynx of children. Acta Otolaryngol (Stockh) 1991;111:1139-45.
8. Stenfors LE, Räisänen S. Secretory IgA-, IgG-and C3b-coated bacteria in the nasopharynx of otitis-prone and non-otitisprone children. Acta Otolaryngol (Stockh) 1993;113:191-5.
9. Mazanec MB, Nedrud JG, Lamm ME. Immunoglobulin A monoclonal antibodies protect against Sendai virus. J Virol 1987;61:2624-6.
10. Tamura S, Funato H, Hirabayashi Y, et al. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules. Eur J Immunol 1991;21:1337-44.
11. Hemmingsson P, Hammarström L. Nasal administration of immunoglobulin as effective prophylaxis against infections in elite cross-country skiers. Scand J Infect Dis 1993;25:783-5.
12. Giraudi V, Riganti C, Torales MR, Sedola H, Gaddi E. Upper respiratory infections in children: response to endonasal administration of IGA. Int J Pediatr Otorhinolaryngol 1997; 39:103-10.
13. Lindberg K, Berglund B. Effect of treatment with nasal IgA on the incidence of infectious disease in world-class canoeists. Int J Sports Med 1996;17:235-8.
14. Gwaltney JM Jr. The common cold. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995:561-6.
15. Douglas RM, Moore BW, Miles HB, et al. Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting. N Engl J Med 1986;314:65-70.
16. Hayden FG, Albrecht JK, Kaiser DL, Gwaltney JM Jr. Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon. N Engl J Med 1986;314:71-5.
17. Douglas RM, Moore B, Miles HB, Pinnock CB. Could preventive intranasal interferon lower the morbidity in children prone to respiratory illness? Med J Aust 1990;152:524-8.
18. Farr BM, Gwaltney JM Jr, Adams KF, Hayden FG. Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds. Antimicrob Agents Chemother 1984;26:31-4.
19. Douglas RG Jr. Prophylaxis and treatment of influenza. N Engl J Med 1990;322:443-50.
20. Hayden FG, Belshe RB, Clover RD, Hay AJ, Oakes MG, Soo W. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med 1989; 321:1696-702.
21. Weltzin R, Traina-Dorge V, Soike K, et al. Intranasal monoclonal IgA antibody to respiratory syncytial virus protects rhesus monkeys against upper and lower respiratory tract infection. J Infect Dis 1996;174:256-61.
22. Kerr MA. The structure and function of human IgA. Biochem J 1990;271:285-96.
23. Mazanec MB, Lamm ME, Lyn D, Portner A, Nedrud JG. Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract. Virus Res 1992;23:1-12.
24. Kvale D, Brandtzaeg P. An enzyme-linked immunosorbent assay for differential quantitation of secretory immunoglobulins of the A and M isotypes in human serum. J Immunol Methods 1986;86:107-14.
25. Mazanec MB, Kaetzel CS, Lamm ME, Fletcher D, Nedrud JG. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci USA 1992;89:6901-5.
26. Wolf HM, Fischer MB, Pühringer H, Samstag A, Vogel E, Eibl MM. Human serum IgA downregulates the release of inflammatory cytokines (tumor necrosis factor-alpha, interleukin-6) in human monocytes. Blood 1994;83:1278-88.
27. Smith LJ, Slavin RG. Epidemiologic considerations in atopic disease. In: Bierman CW, Pearlman DS, eds. Allergic diseases from infancy to adulthood. 2nd ed. Philadephia: Saunders, 1988:121-9.
28. Ruuskanen O, Heikkinen T. Viral-bacterial interaction in acute otitis media. Pediatr Infect Dis J 1994;13:1047-9.
29. Heikkinen T, Ruuskanen O, Waris M, Ziegler T, Arola M, Halonen P. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child 1991;145:445-8.
30. Clements DA, Langdon L, Bland C, Walter E. Influenza A vaccine decreases the incidence of otitis media in 6-to 30-month-old children in day care. Arch Pediatr Adolesc Med 1995;149:1113-7.